ARA 290

ARA-290 is an 11-amino acid linear peptide studied as an innate repair receptor (IRR) agonist. The IRR consists of the erythropoietin receptor and the beta-common (CD131) receptor, which research suggests are involved in the body inflammatory and tissue repair pathways.

Experimental research has explored how the IRR responds following peripheral nerve injury and its influence on the inflammatory response. Studies of ARA-290 to date have been largely preclinical, and human research remains limited. Individual responses vary, and your physician can discuss what is currently known during your consultation.

• May help support the body natural recovery processes
• May help support cardiovascular wellness as part of a routine
• May help support comfort and general wellbeing
• May help support a normal inflammatory response
• May help support healthy insulin sensitivity
• May help support healthy energy levels
• May help support tissue repair processes

Common side effects are generally mild and may include localized reactions at the injection site. Consult with a healthcare provider for a complete list of potential side effects.

Individuals with known allergies to peptide medications or those with specific medical conditions that contraindicate its use should avoid ARA 290. Always consult a healthcare provider to ensure it’s appropriate for your health needs.